Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan
· Delayed Price · Currency is TWD 155.00
-3.50 (-2.21%)
Apr 24, 2025, 1:30 PM CST
Lumosa Therapeutics Revenue
In the year 2024, Lumosa Therapeutics had annual revenue of 39.15M TWD, down -31.21%. Lumosa Therapeutics had revenue of 19.81M in the quarter ending December 31, 2024, with 7.25% growth.
Revenue
39.15M
Revenue Growth
-31.21%
P/S Ratio
683.71
Revenue / Employee
910.56K
Employees
43
Market Cap
26.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.15M | -17.76M | -31.21% |
| Dec 31, 2023 | 56.92M | 30.27M | 113.63% |
| Dec 31, 2022 | 26.64M | 9.28M | 53.45% |
| Dec 31, 2021 | 17.36M | -4.29M | -19.81% |
| Dec 31, 2020 | 21.65M | -150.39M | -87.42% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Center Laboratories | 1.62B |